Luna AM, Michelena MA, Fleming C, Arena G, Chiavassa AM, Rafti P

Language: Spanish
References: 14
Page: 154-157
PDF size: 104.36 Kb.

ABSTRACT

Leishmaniasis is an infection caused by protozoa of the genus Leishmania. Mucocutaneous leishmaniasis is one of the clinical forms that presents more severity, due to the involvement of the upper airway, which can lead to incapacitating consequences or even death.
We report the case of a patient with diagnosis of mucocutaneous leishmaniasis with significant laryngeal involvement which had excellent response to treatment with pentavalent antimonials.

REFERENCES

1. Navarro M, Vilata JJ, Requena C, Aliaga A. Leishmaniasis mucocutánea en un paciente infectado con el VIH. Actas Dermosifiliogr 2000; 91(9): 404-407.

2. Castro Gruber S, Zerpa O, Rondón AJ. Leishmaniasis en la infancia. Med Cut ILA 2003; 31(6): 351-361.

3. Mitropoulos P, Konidas P, Durkin-Konidas M. New World Cutaneous Leishmaniasis: Updated review of current and future diagnosis and treatment. J AM ACAD Dermatol 2010; 63(2): 309-322.

4. Villoldo MS, Forero O, Orduna T, Anaya J, et al. Leishmaniasis mucocutánea. A propósito de un caso. Revisión terapéutica. Act Terap Dermatol 2003; 26(3): 153-157.

5. Sosa Estani S, Salomón O. Aspectos clínicos, epidemiológicos y entomológicos de la transmisión de la leishmaniasis en la República Argentina. Sociedad Iberoamericana de información científica (SIIC) 2001

6. Acosta A, Restifo EJ. Apuntes sobre leishmaniasis. Actualización 2008. Arch Argent Dermatol 2008; 58(2): 47-54.

7. Borgia F, Vaccaro M, Guarneri F, Manfre C, et al. Mucosal leishmaniasis occurring in a renal transplant recipient. Dermatology 2001; 202(3): 266-267

8. Urrutia S. Leishmaniasis cutánea. Piel 2001; 16: 253-257.

9. Falú MA, García Bustos MF, Parodi Ramoneda CM, Raspi EM, et al. Susceptibilidad de distintas cepas de ratones a la infección por Leishmania amazonensis. Dermatol Argent 2009; (15)5: 334-339.

10. Motta AC, Arruda D, Souza CS, Foss NT. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. Int J Dermatol 2003; 42(9): 703-706.

11. Bodet E. Leishmaniasis laríngea: presentación de dos casos clínicos. ORL-DIPS 2002; 29(3): 131-134.

12. Desjeux P. Leishmaniasis Public Health Aspects and Control. Clin Dermatol 1996; 14: 417-423.

13. Velozo D, Machado Ribeiro MC, Carvalho Costa IM, Cabral A, et al. Fatal mucosal leishmaniasis in a child. An Bras Dermatol 2006; 81(3): 255-259.

14. Onuma H, Matsui C, Inoue K, Uezato N, et al. A case of mucosal leishmaniasis: beneficial usage of polymerase chain reaction for diagnosis. Int J Dermatol 2001; 40: 765-767.